News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Lis William
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/30/2023 |
4
| Lis William (Director) has filed a Form 4 on Zai Lab Ltd|
Txns:
| Granted 18,903 shares
@ $26.45, valued at
$500k
|
|
| 06/08/2023 |
4
| Lis William (Director) has filed a Form 4 on Jasper Therapeutics, Inc.|
Txns:
| Granted 47,000 options to buy
@ $1.6, valued at
$75.2k
|
|
| 04/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/07/2023 |
4
| Lis William (Director) has filed a Form 4 on Zai Lab Ltd|
Txns:
| Sold 5,434 shares
@ $38.31, valued at
$208.2k
|
|
| 10/13/2022 |
4
| Lis William (Director) has filed a Form 4 on Jasper Therapeutics, Inc.|
Txns:
| Granted 29,500 shares
@ $0 |
|
| 06/28/2022 |
4
| Lis William (Director) has filed a Form 4 on Jasper Therapeutics, Inc.|
Txns:
| Sold 24,743 shares
@ $2.022, valued at
$50k
Sold 24,743 shares
@ $2.0775, valued at
$51.4k
|
|
| 03/23/2022 |
4
| Lis William (See Remarks) has filed a Form 4 on Jasper Therapeutics, Inc.|
Txns:
| Granted 89,972 shares
@ $0
Granted 7,500 options to buy
@ $3.54, valued at
$26.6k
Granted 89,972 options to buy
@ $3.54, valued at
$318.5k
Granted 100,000 options to buy
@ $3.54, valued at
$354k
|
|
| 01/21/2022 |
4
| Lis William (Director) has filed a Form 4 on Zai Lab Ltd|
Txns:
| Sold 1,926 shares
@ $53.4, valued at
$102.8k
|
|
| 01/04/2022 |
4
| Lis William (Director) has filed a Form 4 on Zai Lab Ltd|
Txns:
| Granted 7,763 shares
@ $0 |
|
| 01/28/2021 |
4
| Lis William (Director) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Disposed/sold 21,528 options to buy
@ $48.51, valued at
$1M
Disposed/sold 21,528 options to buy
@ $30.87, valued at
$664.6k
Disposed/sold 43,056 options to buy
@ $13.67, valued at
$588.6k
|
|
| 01/20/2021 |
4
| Lis William (Director) has filed a Form 4 on Zai Lab Ltd|
Txns:
| Granted 3,852 shares
@ $0 |
|
| 05/29/2020 |
4
| Lis William (Director) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Granted 21,528 options to buy
@ $48.51, valued at
$1M
|
|
| 06/13/2019 |
4
| Lis William (Director) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Granted 21,528 options to buy
@ $30.87, valued at
$664.6k
|
|
| 12/07/2018 |
4
| Lis William (Director) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Granted 43,056 options to buy
@ $13.67, valued at
$588.6k
|
|
| 08/28/2018 |
4
| Lis William (CEO) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC|
Txns:
| Exercised 35,000 shares
@ $0
Paid exercise price by delivering 17,587 shares
@ $26.05, valued at
$458.1k
|
|
| 06/08/2018 |
4
| Lis William (CEO) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC|
Txns:
| Sold 5,113 shares
@ $45.21, valued at
$231.2k
|
|
| 05/24/2018 |
4
| Lis William (CEO) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC|
Txns:
| Granted 12,890 shares
@ $0
Paid exercise price by delivering 6,491 shares
@ $40.82, valued at
$265k
|
|
| 03/06/2018 |
4
| Lis William (CEO) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 19,184 shares
@ $32.53, valued at
$624.1k
|
|
| 02/02/2018 |
4
| Lis William (CEO) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC|
Txns:
| Granted 25,000 shares
@ $0
Granted 100,000 options to buy
@ $51.31, valued at
$5.1M
|
|
| 08/18/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/11/2017 |
4
| Lis William (CEO) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC|
Txns:
| Sold 6,750 shares
@ $36.06, valued at
$243.4k
|
|
| 03/03/2017 |
4
| Lis William (CEO) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 13,669 shares
@ $38.61, valued at
$527.8k
|
|
| 02/01/2017 |
4
| Lis William (CEO) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC|
Txns:
| Granted 34,375 shares
@ $0
Granted 137,500 options to buy
@ $25.54, valued at
$3.5M
Granted 34,375 rights
@ $0 |
|
| 05/03/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/03/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/04/2016 |
4
| Lis William (CEO) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 3,492 shares
@ $31.75, valued at
$110.9k
|
|
|
|